The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Authorities at Makerere University and Alfasan Uganda Limited have said they seek Shs42 billion for full scale production of an anti-tick vaccine for commercialization ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more Fleas and ticks are harmful parasites that can cause a number of health issues in dogs. The best flea ...

A trial aiming to use bugs to treat type 1 diabetes has been awarded funding. The University of Oxford has been given a share ...

To avoid tick-borne diseases you should wear long-sleeved ... shows off his trim frame after revealing which weight loss drug he used to shed 60lbs Quite a difference Jodie Comer supports ...

Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

R. parkeri rickettsiosis is an emerging tick-borne disease similar to Rocky Mountain spotted fever with relatively milder symptoms in the United States, according to CAES. R. parkeri rickettsiosis ...

WASHINGTON (AP) — US applications for unemployment benefits tick up slightly, but layoffs remain at historically low levels.

Telix's brain cancer diagnostic Pixclara could become the company's second approved product  in the US following a key ...

Authorities at Makerere University and Alfasan Uganda Limited have said they seek Shs42 billion for full scale production of an anti-tick vaccine for commercialization ...